ReviewCurrent hematologic malignancy reports2017

Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy.

Andrew D Fesnak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.